Adagene (ADAG) Competitors $1.94 +0.09 (+4.86%) Closing price 07/2/2025 03:59 PM EasternExtended Trading$1.95 +0.01 (+0.52%) As of 05:44 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADAG vs. RZLT, UPXI, TERN, ARCT, CMPX, ATXS, SNDL, GOSS, MBX, and AQSTShould you be buying Adagene stock or one of its competitors? The main competitors of Adagene include Rezolute (RZLT), Upexi (UPXI), Terns Pharmaceuticals (TERN), Arcturus Therapeutics (ARCT), Compass Therapeutics (CMPX), Astria Therapeutics (ATXS), SNDL (SNDL), Gossamer Bio (GOSS), MBX Biosciences (MBX), and Aquestive Therapeutics (AQST). These companies are all part of the "pharmaceutical products" industry. Adagene vs. Its Competitors Rezolute Upexi Terns Pharmaceuticals Arcturus Therapeutics Compass Therapeutics Astria Therapeutics SNDL Gossamer Bio MBX Biosciences Aquestive Therapeutics Rezolute (NASDAQ:RZLT) and Adagene (NASDAQ:ADAG) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation. Does the media favor RZLT or ADAG? In the previous week, Adagene had 1 more articles in the media than Rezolute. MarketBeat recorded 4 mentions for Adagene and 3 mentions for Rezolute. Rezolute's average media sentiment score of 1.54 beat Adagene's score of 0.43 indicating that Rezolute is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rezolute 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Adagene 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate RZLT or ADAG? Rezolute presently has a consensus price target of $11.83, indicating a potential upside of 143.48%. Adagene has a consensus price target of $8.00, indicating a potential upside of 312.37%. Given Adagene's higher possible upside, analysts clearly believe Adagene is more favorable than Rezolute.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rezolute 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14Adagene 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is RZLT or ADAG more profitable? Adagene's return on equity of 0.00% beat Rezolute's return on equity.Company Net Margins Return on Equity Return on Assets RezoluteN/A -70.09% -63.08% Adagene N/A N/A N/A Do insiders & institutionals believe in RZLT or ADAG? 83.0% of Rezolute shares are held by institutional investors. Comparatively, 9.5% of Adagene shares are held by institutional investors. 18.4% of Rezolute shares are held by insiders. Comparatively, 21.2% of Adagene shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more risk and volatility, RZLT or ADAG? Rezolute has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500. Comparatively, Adagene has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500. Which has preferable earnings and valuation, RZLT or ADAG? Adagene has higher revenue and earnings than Rezolute. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRezoluteN/AN/A-$68.46M-$1.15-4.23Adagene$100K913.93-$33.42MN/AN/A SummaryAdagene beats Rezolute on 7 of the 13 factors compared between the two stocks. Get Adagene News Delivered to You Automatically Sign up to receive the latest news and ratings for ADAG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ADAG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADAG vs. The Competition Export to ExcelMetricAdageneMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$87.15M$2.88B$5.54B$8.87BDividend YieldN/A2.64%5.39%4.10%P/E RatioN/A21.3126.2319.90Price / Sales913.93278.47413.23113.66Price / CashN/A41.4736.1356.90Price / Book1.707.518.045.38Net Income-$33.42M-$55.05M$3.15B$248.50M7 Day Performance2.11%2.07%1.44%2.04%1 Month Performance-6.28%4.84%3.62%4.84%1 Year Performance-33.10%5.37%34.68%20.23% Adagene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADAGAdagene1.9963 of 5 stars$1.94+4.9%$8.00+312.4%-35.1%$87.15M$100K0.00260RZLTRezolute3.1477 of 5 stars$4.03-1.9%$11.83+193.6%+15.4%$351.48MN/A-3.5040UPXIUpexi3.3132 of 5 stars$10.00+8.1%$16.00+60.0%-68.0%$350.72M$26M0.00130Upcoming EarningsTERNTerns Pharmaceuticals4.1045 of 5 stars$3.68-5.6%$15.63+324.6%-36.6%$340.61MN/A-3.3840Positive NewsARCTArcturus Therapeutics3.7811 of 5 stars$12.51+1.8%$53.50+327.7%-36.6%$333.31M$152.31M-4.94180News CoverageAnalyst ForecastCMPXCompass Therapeutics3.0594 of 5 stars$2.54+5.8%$13.13+416.7%+197.7%$331.88M$850K-6.2020News CoverageAnalyst UpgradeATXSAstria Therapeutics1.8469 of 5 stars$5.61-4.3%$30.00+434.8%-36.1%$330.70MN/A-3.0030News CoverageSNDLSNDL3.9501 of 5 stars$1.24-0.8%$3.63+192.3%-33.5%$328.47M$671.81M-4.282,516Positive NewsGOSSGossamer Bio3.6963 of 5 stars$1.37-4.9%$7.75+465.7%+26.1%$327.32M$124.59M-5.96180Gap DownMBXMBX Biosciences2.3265 of 5 stars$9.73-0.1%$37.50+285.4%N/A$325.22MN/A0.0036AQSTAquestive Therapeutics1.415 of 5 stars$3.29+1.2%$10.14+208.3%+52.1%$322.82M$57.56M-5.58160News Coverage Related Companies and Tools Related Companies RZLT Competitors UPXI Competitors TERN Competitors ARCT Competitors CMPX Competitors ATXS Competitors SNDL Competitors GOSS Competitors MBX Competitors AQST Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADAG) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.President Donald Trump made headlines last month with a staggering claim. He stated that since taking offic...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredMake 22x more from this summer’s Bitcoin boomBitcoin is on fire again. Wall Street’s piling in. ETFs are smashing volume records. And regular investors ...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adagene Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Adagene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
